Search results

Narrow your search

Result types

Showing 11 - 20 of 63 for "LexOrbis" with applied filters

News & Analysis

Biological Material and Written Description Requirement under Patent Law

29 January 2024 by DPS Parmar (Special Counsel)

The three tenets of a patent grant are possession, disclosure, and claims of invention.

News & Analysis

Quid Pro Quo of Patent Bargain: Disclosure of Invention

16 January 2024 by Manisha Singh (Partner) & Vaneet Kaur (Managing Associate)

The exclusive right of a patentee to stop others from making or using their invention for a defined period is balanced by the obligation to disclose the invention in detail.

News & Analysis

“Known Substance” Must be Disclosed Before the Date of Priority for Section 3(d) of Patents Act: Madras High Court

02 January 2024 by Manisha Singh (Partner) & Avi Garg (Partner)

Non-patentable inventions are always a bone of contention between the applicant and the patent office.

News & Analysis

Roche v DCGI: Delhi High Court on Rejection of Plaints and Doctrine of Passing Off

21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits

News & Analysis

Designing around patent is considered legitimate

13 December 2023 by DPS Parmar

It is common to find competitive inventors to work on the uncovered aspect of a patent claim and design around it to escape the sword of infringement.

News & Analysis

LexOrbis Strengthens its IP Footprint with Chennai Expansion

04 December 2023 by LexOrbis - India

LexOrbis is delighted to announce the opening of its new office in Chennai, India.

News & Analysis

Effects of the Draft Patent Rules, 2023 on Pharma Industry

30 November 2023 by Manisha Singh (Partner) & Harshini A. (Trainee Associate)

A couple of months back, the Ministry of Commerce and Industry published the Draft Patents (Amendment) Rules,2023, with various changes to the rules, regulations and fees, which welcomed suggestions and objections from the public.

News & Analysis

IP Courts Revisiting the Scope of Claims Amendment

20 November 2023 by LexOrbis : Neha Ruhela (Senior Associate)

After the milestone verdict of the Delhi High Court in Allergan v Controller (2023:DHC:515), now it is time for patent strategists to rejoice over landmark judgments of the Madras High Court, including Starpharma Pty Ltd. v Controller (2023/MHC/4638) that provide similar liberal interpretations of amendment of claims under Section 59 of the Patents Act, 1970.

News & Analysis

Relooking at the reach of Section 3(d) of the Indian Patents Act, 1970 after ‘Novozymes’ Case

30 October 2023 by LexOrbis - DPS Parmar

Section 3(d) of the Indian Patents Act, 1970 was never so controversial till the insertion of an amendment in 2005, which states that “the mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance".

News & Analysis

Analysing the Department of Biotechnology (DBT) Intellectual Property Guidelines 2023

16 October 2023 by LexOrbis - India : Manisha Singh (Partner) & Shikha Singh (Managing Associate)

With increasing awareness of securing intellectual property rights and deriving value from them, the commercialisation of patents is an important aspect.